Month: September 2025

Conversion is the ‘untold’ story of hospitality industry: Hilton
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Alan Watts, President of Hilton APAC, highlights the growing investment in brand conversions, where existing properties switch to new brands—a strategy proving highly effective for Hilton in the region. He also talks about immense opportunities in India, fueled by infrastructure boom. 02:06 […]
Read More
Mortgage rates drop to 3-year low ahead of Fed meeting
Mortgage rates dropped sharply Tuesday, as investors in mortgage-backed bonds seemed to buy in ahead of a widely expected rate cut by the Federal Reserve. The average rate on the 30-year fixed mortgage dropped 12 basis points from Monday to 6.13%, according to Mortgage News Daily. That is the lowest level since late 2022. “The […]
Read More
Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Wednesday said its experimental pill outperformed Novo Nordisk‘s own oral drug in the first head-to-head study comparing the two medicines in patients with Type 2 diabetes. The […]
Read More
Healthy Returns: What to know about RFK Jr.’s five new vaccine panel members
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., testifies before a Senate Finance Committee hearing on President Donald Trump’s 2026 health care agenda, on Capitol Hill in Washington, D.C., U.S., September 4, 2025. Jonathan Ernst | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest […]
Read More
Jim Cramer says Eli Lilly’s obesity pill could be more of a ‘lifetime drug’ than shots
Don’t count out Eli Lilly’s oral GLP-1 drug for obesity and diabetes just yet, according to CNBC’s Jim Cramer . That was his takeaway following the latest study involving Lilly’s orforglipron, the experimental pill that has been the subject of Wall Street debate since weight-loss data released in early August came in below investor expectations. […]
Read More
Wegovy-maker Novo Nordisk to cut around 9,000 jobs
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images Danish pharmaceutical giant Novo Nordisk on Wednesday announced plans to cut around 9,000 roles, or roughly 11.5% of its global workforce. “Novo Nordisk today announced a company-wide transformation to simplify its organisation, improve the speed […]
Read More
UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says
U.S. policymakers should take note as biopharmaceutical companies pull back on investments in the U.K., Eli Lilly Chief Executive Officer Dave Ricks said in an interview with CNBC. Lilly recently paused plans to create a biotech incubator called Gateway Labs in the U.K., joining other biopharma companies that have put investments in the country on […]
Read More
United Airlines CEO confident in flight expansion ‘because customers are choosing us’
Scott Kirby, CEO of United Airlines, speaks during the WSJ’s Future of Everything 2025 at the Glasshouse on May 29, 2025 in New York City. Michael M. Santiago | Getty Images NEWARK, New Jersey — An oversupply of flights forced airlines to cut fares this year and pushed carriers to scale back their growth plans. […]
Read More